Abstract CT007: Entrectinib, an oral pan-Trk, ROS1, and ALK inhibitor in TKI-naïve patients with advanced solid tumors harboring gene rearrangements: Updated phase I results
暂无分享,去创建一个
A. Drilon | A. Shaw | S. Ou | M. Ahn | R. Doebele | Rupal A Patel | Jeeyun Lee | S. Siena | A. Farago | P. Multani | Stephen V. Liu | F. Braud | T. Bauer | E. C. Maneval | M. Patel | D. Luo | Natasha Reddinger